This invention relates to compounds that are antagonists of dopamine D4 receptors having Formula I below <IMAGE> I This invention also relates to methods of treating psychosis and schizophrenia using a compound that is an antagonist of dopamine D4 receptors, and to pharmaceutically acceptable compositions that contain a dopamine D4 receptor antagonist.
Tetrahydroquinoxaline dopamine D4 receptor antagonists